RCEL
AVITA Medical, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$11.20
+2.38%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 382.67x
- P/S forward
- 3.49x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -12.44x
- Price / sales
- 4.58x
- Price / cash flow
- -14.30x
Enterprise value
- Enterprise value
- $383.7M
- EV / sales
- 5.07x
- EV / EBITDA
- -11.15x
- EV / EBIT
- -10.90x
- Market cap
- $346.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026